SFS
BBIO icon

Sowell Financial Services’s BridgeBio Pharma BBIO Stock Holding History

Sowell Financial Services’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,508
Closed -$75K – 729
2021
Q1 		$75K Sell
1,508
-327
-18% -$21.4K ﹤0.01% 1495
2020
Q4 		$130K Sell
1,835
-940
-34% -$45.3K 0.01% 1050
2020
Q3 		$104K Sell
2,775
-1,957
-41% -$61.6K 0.01% 959
2020
Q2 		$154K Buy
+4,732
New +$144K 0.01% 816

Other funds holding BBIO

KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
AIG
American International Group New York $2.93M AUM 12.08% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sowell Financial Services's BBIO Position: Q2 2021 in Review

Sowell Financial Services sold out of BridgeBio Pharma (BBIO) in Q2 2021, closing a stake of 1,508 shares — an estimated $75K sold.

Sowell Financial Services first reported a position in BBIO in Q2 2020 and held it in 4 quarters. The position peaked at $154K in Q2 2020. 201 funds tracked by Wall St. Rank hold BBIO as of Q2 2021.

  • Sowell Financial Services reported no remaining BridgeBio Pharma position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 1,508 BridgeBio Pharma shares in Q2 2021, an estimated $75K.
  • Sowell Financial Services first reported a position in BridgeBio Pharma in Q2 2020 and held it in 4 quarters.
  • Sowell Financial Services's BridgeBio Pharma position peaked at $154K in Q2 2020.
  • 201 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.